Pharmaco(Epi)Genetic Study of Obsessive-Compulsive Disorder
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pharmaco(epi)genetic study predict
selective serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance
of the drug effect until 4 months(16 weeks), 6 months, and 1 year after administration of
SSRIs.